Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3036005	u-sakkaa	— (—)	45	49	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Intestinal infectious diseases

4.10

5.55

1.0

1.1

—

Other diseases of spinal cord

+∞

5.21

1.4

0.0

—

Disorders of gallbladder, biliary tract and pancreas

4.24

5.09

1.0

1.2

—

Other bacterial diseases

4.14

5.06

1.0

1.2

—

Oral corticosteroids

3.83

5.01

1.2

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

3.78

4.83

1.2

1.0

—

Oxycodone

7.77

4.73

1.0

1.2

—

Early onset COPD, excluding more controls

13.99

4.57

1.1

1.2

—

Constipation

4.42

4.44

1.2

1.0

—

Other bacterial diseases, including avohilmo

3.74

4.41

1.1

—

First line medication for Crohn's disease

3.84

4.31

1.2

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

8.00

4.05

1.0

1.1

—

Chronic lower respiratory diseases

3.31

4.02

1.1

—

ILD medications

3.32

3.82

1.2

1.0

—

Inflammatory bowel disease treatment related agents

3.29

3.81

1.2

1.0

—

Dyspnoea

3.88

3.79

1.1

—

Exclusions for E4_PCOS_BROAD

12.00

3.76

1.0

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3.45

3.75

1.0

1.2

—

Renal tubulo-interstitial diseases

3.80

3.72

1.1

—

Tramadol

5.09

3.69

1.0

1.3

—

Asthma (only as main-diagnosis)

5.12

3.65

1.0

1.2

—

Asthma (only as main-diagnosis), excluding more controls

5.07

3.61

1.0

1.2

—

Early onset COPD

7.78

3.55

1.1

—

3.30

3.50

1.0

1.2

—

All kidney diseases

3.23

3.48

1.1

—

Disorders of the thyroid gland

3.24

3.46

1.1

—

Asthma (mode)

4.81

3.44

1.0

1.3

—

Asthma

4.73

3.38

1.0

1.2

—

Asthma, excluding more controls

4.70

3.37

1.0

1.2

—

Codeine

4.05

3.26

1.0

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6.30

3.25

1.0

1.3

—

COPD (mode)

9.36

3.22

1.2

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

3.85

3.18

1.0

1.2

—

GASTRO-related operations

6.69

3.17

1.1

1.3

—

Any gastric operation

6.69

3.17

1.1

1.3

—

Disorders of other endocrine glands

5.25

3.14

1.0

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

4.12

3.13

1.0

1.2

—

Other chronic obstructive pulmonary disease

5.45

3.13

1.1

—

COPD

5.41

3.11

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs

8.29

3.09

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

8.22

3.08

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

5.00

3.04

1.0

1.3

—

Acute tubulo-interstitial nephritis

4.02

3.02

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.64

3.01

1.0

1.1

—

Diplopia

10.01

2.98

1.0

1.2

—

Carbimazole or st.post thyroidectomy, condition for graves disease

10.00

2.98

1.2

1.0

—

Acute pancreatitis

10.00

2.98

1.0

1.4

—

Acute pancreatitis (for exclusion)

10.00

2.98

1.0

1.4

—

Intestinal infectious diseases, including avohilmo, including avohilmo

3.00

2.95

1.0

1.2

—

Cholecystectomy

3.59

2.95

1.0

1.2

—

Other reaction to severe stress, and adjustment disorders

4.70

2.91

1.0

1.2

—

All chronic kidney diseases

4.22

2.85

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

3.16

2.80

1.0

1.1

—

Caries of dentine

6.43

2.79

1.0

1.3

—

Malignant neoplasm

3.58

2.77

1.1

1.2

—

Malignant neoplasm

3.58

2.77

1.1

1.2

—

Solid cancers, including Hilmo

3.56

2.75

1.1

1.2

—

Thyrotoxicosis

8.34

2.75

1.2

1.0

—

Cholelithiasis

3.41

2.72

1.0

1.2

—

Abnormalities of breathing

3.12

2.72

1.1

—

Codeine or tramadol medication

2.81

2.67

1.0

1.1

—

Benzodiazepine use

2.83

2.66

1.0

1.1

—

Certain infectious and parasitic diseases

3.85

2.64

1.3

1.1

—

Cholelithiasis, broad definition with cholecystitis

3.33

2.64

1.0

1.2

—

Hallux valgus (acquired)

5.00

2.58

1.0

1.2

—

Chronic rhinitis, nasopharyngitis and pharyngitis

5.45

2.54

1.2

1.3

—

Malignant neoplasm, including Hilmo

3.20

2.48

1.1

1.2

—

COPD, hospital admissions

3.96

2.48

1.1

—

Malignant neoplasm, wide definition

3.20

2.48

1.1

1.2

—

COPD, early/later onset

3.95

2.47

1.1

—

COPD/asthma related infections

3.00

2.47

1.1

1.2

—

COPD/asthma/ILD related infections

3.00

2.47

1.1

1.2

—

Other headache syndromes

4.36

2.46

1.0

1.3

—

Diseases of oesophagus, stomach and duodenum

2.74

2.44

1.0

1.1

—

Asthma, unspecified (mode)

4.59

2.43

1.0

1.3

—

Persons encountering health services in other circumstances

3.77

2.43

1.0

—

Dental caries

5.15

2.42

1.0

1.3

—

Other chronic obstructive pulmonary disease, including avohilmo

3.86

2.42

1.1

—

Autoimmune diseases related-to ILD

2.96

2.42

1.3

1.0

—

Asthma, unspecified (mode), excluding more controls

4.55

2.41

1.0

1.3

—

Other abnormal uterine and vaginal bleeding

7.18

2.39

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

6.25

2.37

1.4

1.1

—

Other strabismus

6.23

2.36

1.0

1.4

—

Solid cancers

3.26

2.34

1.1

1.2

—

Any reimbursement code in KELA

6.01

2.34

1.5

1.0

—

Viral and other specified intestinal infections

6.10

2.33

1.0

1.4

—

Pain, not elsewhere classified

4.62

2.27

1.0

1.3

—

Bronchitis

2.60

2.25

1.0

1.1

—

3.86

2.23

1.0

1.2

—

Acute sinusitis

3.46

2.23

1.0

1.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

3.10

2.22

1.0

1.1

—

Irritable bowel syndrome

5.56

2.21

1.0

1.3

—

Strabismus

5.54

2.21

1.0

1.3

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

5.39

2.16

1.0

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

2.97

2.16

1.0

1.1

—

Other acute lower respiratory infections

3.31

2.15

1.0

1.2

—

Renal failure

3.73

2.12

1.0

1.1

—

Other septicaemia, including avohilmo

3.65

2.11

1.1

—

Anxiety disorders, excluding more controls

2.90

2.11

1.0

1.1

—

Chronic kidney disease

4.12

2.07

1.0

1.1

—

Venous thromboembolism

3.55

2.07

1.0

1.1

—

Mouth breathing

3.99

2.03

1.0

1.1

—

Viral and other specified intestinal infections, including avohilmo

4.81

2.00

1.0

1.3

—

Other soft tissue disorders, not elsewhere classified

2.53

1.96

1.0

1.1

—

Heart failure, not strict

2.88

1.94

1.0

1.1

—

Obesity related asthma

4.55

1.94

1.0

1.2

—

All influenza

4.55

1.94

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2.52

1.93

1.0

1.1

—

Other and unspecified tonsillitis

3.83

1.92

1.0

1.2

—

Other neurological diseases

2.79

1.92

1.2

1.1

—

Acute bronchitis

3.68

1.89

1.0

1.3

—

Asthma-related infections

2.89

1.87

1.0

1.1

—

Asthma, hospital admission 2, infections

2.89

1.87

1.0

1.1

—

Noninfective enteritis and colitis

3.18

1.87

1.0

1.2

—

Sleep apnoea, including avohilmo

2.56

1.87

1.0

1.2

—

Visual disturbances and blindness

2.85

1.85

1.0

1.1

—

COPD related to multimorbidity

3.62

1.83

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

4.11

1.80

1.4

1.2

—

Artrosis, including avohilmo

0.00

1.80

0.0

1.1

—

Bacterial infection, other or unspecified

3.11

1.79

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

2.44

1.78

1.0

1.1

—

Asthma, including avohilmo

2.31

1.78

1.0

1.1

—

Anxiety disorders

2.43

1.77

1.0

1.1

—

Other diseases of upper respiratory tract

2.40

1.75

1.1

—

Explicit Sepsis, including avohilmo

3.40

1.75

1.2

1.1

—

Other heart diseases

3.54

1.73

1.0

1.4

—

Any event in cancer register

2.65

1.71

1.1

—

Persons encountering health services in other circumstances, wide

2.37

1.71

1.2

1.0

—

Appendectomy

2.62

1.68

1.0

1.1

—

Hypothyroidism, other/unspecified

2.53

1.66

1.1

—

Viral infections characterized by skin and mucous membrane lesions

3.16

1.66

1.0

1.2

—

2.84

1.65

1.0

1.2

—

Bacterial infection, other or unspecified, including avohilmo

2.87

1.65

1.0

1.1

—

Gastro-oesophageal reflux disease

2.59

1.63

1.0

1.2

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.77

1.63

1.0

1.2

—

Mental and behavioural disorders due to psychoactive substance use

2.79

1.62

1.0

1.2

—

Other disorders of lacrimal gland

3.57

1.61

1.2

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2.43

1.61

1.0

1.2

—

Asthma (diagnoses ohter than nonallergic)

2.31

1.56

1.0

1.1

—

Other septicaemia

2.98

1.55

1.0

1.1

—

Erysipelas, including avohilmo

2.73

1.54

1.0

1.1

—

ILD medications: immunosuppressive drugs

2.64

1.53

1.4

1.0

—

2.65

1.52

1.0

1.2

—

Intestinal stricture

3.33

1.52

1.2

1.1

—

Substance abuse, excluding more controls

2.95

1.52

1.0

1.1

—

Other diseases of pleura

2.90

1.50

1.0

1.1

—

Septicaemia

2.88

1.50

1.0

1.1

—

Other diseases of intestines

2.27

1.48

1.1

—

Exposure to unspecified factor

2.20

1.46

1.0

1.1

—

Visual disturbances

2.50

1.45

1.0

1.1

—

Certain infectious and parasitic diseases, including avohilmo

3.58

1.44

1.2

1.0

—

Zoster [herpes zoster], including avohilmo

2.76

1.44

1.0

1.1

—

Parasetamol

3.03

1.44

1.2

—

Complications of procedures, not elsewhere classified

2.34

1.43

1.1

—

Acute upper respiratory infections

2.20

1.41

1.0

1.1

—

Erysipelas

2.72

1.40

1.0

1.1

—

Mood disorders, excluding more controls

2.30

1.38

1.0

1.1

—

Asthma/COPD (KELA code 203)

2.23

1.35

1.0

1.1

—

Hernia

2.21

1.34

1.1

—

Polycystic ovarian syndrome, consortium definition

2.55

1.34

1.3

1.1

—

COPD, hospital admission 2, with asthma infections

2.87

1.30

1.0

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2.18

1.30

1.1

—

Disorders of eyelid, lacrimal system and orbit

2.13

1.30

1.1

—

Pneumonia, organism unspecified

2.13

1.29

1.1

—

Osteopathies and chondropathies

2.49

1.28

1.2

1.0

—

Spondylopathies

2.36

1.28

1.1

—

Varicose veins

2.52

1.27

1.0

1.1

—

Other antidepressants

2.22

1.27

1.1

—

Substance abuse

2.42

1.24

1.0

1.2

—

Complications of medical and surgical care

2.25

1.24

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

2.22

1.24

1.1

—

Unspecified haematuria

2.71

1.22

1.0

1.1

—

Explicit Sepsis

2.68

1.22

1.0

1.1

—

Sensorineural hearing loss

2.22

1.22

1.0

1.1

—

Any mental disorder

2.18

1.21

1.2

1.1

—

DVT of lower extremities and pulmonary embolism

2.62

1.21

1.0

1.1

—

Major coronary heart disease event excluding revascularizations

0.00

1.20

0.0

1.1

—

Disorders of lacrimal system

2.59

1.19

1.2

—

Malaise and fatigue

2.36

1.19

1.0

1.2

—

Diseases of inner ear

2.30

1.17

1.3

1.1

—

Concussion

2.58

1.16

1.0

1.1

—

Injuries to the thorax

2.50

1.15

1.0

1.1

—

Implicit bacterial Sepsis

2.52

1.14

1.0

1.1

—

Low back pain

2.08

1.14

1.0

1.1

—

Other diseases of urinary system

2.08

1.13

1.3

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.04

1.12

1.0

1.1

—

Depression

2.02

1.11

1.0

1.1

—

Other medical care

2.47

1.11

1.0

1.1

—

Complications of surgical and medical care, not elsewhere classified

2.02

1.11

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.29

1.11

1.1

—

Implicit bacterial Sepsis, including avohilmo

2.45

1.10

1.0

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2.41

1.10

1.0

1.2

—

Bacterial Sepsis

2.43

1.09

1.0

1.1

—

Other functional intestinal disorders

2.39

1.08

1.2

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.04

1.08

1.3

1.0

—

Sleep apnoea

2.02

1.06

1.0

1.1

—

Diseases of the respiratory system

2.51

1.05

1.2

—

Irregular menses

2.35

1.04

1.4

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.89

1.00

1.0

1.1

—

Mood [affective] disorders

1.94

1.00

1.0

1.1

—

Symptoms and signs involving the urinary system

2.03

1.00

1.0

1.2

—

Disorders of vestibular function (Vertigo)

2.21

1.00

1.4

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.88

0.99

1.2

1.1

—

Other pulmonary diagnosis

2.50

0.99

1.0

1.2

—

Excluding asthma or asthma-COPD overlap

2.50

0.99

1.0

1.2

—

Type 2 diabetes, strict (exclude DM1)

1.87

0.98

1.0

1.1

—

Type 2 diabetes, definitions combined

1.87

0.98

1.0

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

1.86

0.98

1.0

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.00

0.98

0.0

1.1

—

Fracture of forearm

0.00

0.97

0.0

1.1

—

All pneumoniae

1.83

0.96

1.1

—

Allergic conjunctivitis

0.00

0.96

0.0

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.81

0.96

1.1

—

Conductive and sensorineural hearing loss

1.94

0.94

1.0

1.1

—

Mood disorders

1.88

0.93

1.0

1.1

—

Diseases of arteries, arterioles and capillaries

2.20

0.92

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2.18

0.92

1.0

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2.00

0.91

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.14

0.91

1.2

1.1

—

Pain in limb

1.95

0.90

1.0

1.2

—

Insulin medication

2.07

0.89

1.0

1.2

—

Neurological diseases

1.91

0.88

1.4

1.0

—

Episodal and paroxysmal disorders

1.88

0.88

1.0

1.1

—

Presence of other functional implants

2.05

0.87

1.0

1.1

—

Falls/tendency to fall

1.85

0.85

1.2

1.1

—

Fall on same level

1.78

0.85

1.2

1.1

—

Excessive earwax

1.94

0.84

1.0

1.1

—

Pregnancy, childbirth and the puerperium

0.00

0.83

0.0

1.0

—

Dorsalgia

1.83

0.80

1.0

1.1

—

Lower back pain or/and sciatica

1.77

0.80

1.0

1.1

—

Hypertension, essential

1.88

0.79

1.0

1.1

—

Transport accidents

0.00

0.79

0.0

1.1

—

Injuries to the hip and thigh

0.00

0.79

0.0

1.1

—

Disorders of breast

0.00

0.79

0.0

1.1

—

Type 2 diabetes

1.80

0.79

1.0

1.1

—

Influenza and pneumonia

1.79

0.78

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.78

0.0

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

1.78

0.78

1.1

—

Opioids

2.01

0.78

1.0

1.2

—

Endocrine, nutritional and metabolic diseases

1.96

0.77

1.1

1.2

—

Inguinal hernia

2.21

0.77

1.2

1.1

—

Persons encountering health services for specific procedures and health care

1.71

0.76

1.0

1.1

—

Mental and behavioural disorders due to alcohol

2.16

0.76

1.0

1.2

—

Sciatica+with lumbago

2.11

0.75

1.0

1.1

—

Intracranial trauma

2.11

0.75

1.0

1.1

—

Insulin, intermediate and long-acting

2.10

0.74

1.0

1.1

—

Injuries to the wrist and hand

1.66

0.74

1.0

1.1

—

Injury, poisoning and certain other consequences of external causes

2.09

0.73

1.2

—

Spondylosis

2.06

0.73

1.2

1.1

—

COPD differential diagnosis

2.09

0.73

1.0

1.3

—

ILD differential diagnosis

2.09

0.73

1.0

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

1.82

0.73

1.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

2.04

0.73

1.0

1.3

—

Alcohol use disorder, Swedish definition

1.97

0.72

1.0

1.2

—

Unspecified fall

1.96

0.71

1.0

1.2

—

Diabetes medication

1.59

0.71

1.0

1.1

—

Psychiatric diseases

1.67

0.67

1.0

1.1

—

Exposure to other specified factors

1.62

0.66

1.1

—

Abdominal and pelvic pain

1.75

0.65

1.0

1.2

—

Finngen Rheumatological endpoints

1.68

0.64

1.0

1.1

—

Any death

1.75

0.64

1.0

1.1

—

Disorders of sclera, cornea, iris and ciliary body

1.72

0.64

1.0

1.1

—

Fever of other and unknown origin

1.73

0.64

1.0

1.2

—

Use of hypnotics and sedatives

1.63

0.62

1.0

1.1

—

Used for control exclusion in common control thyroid runs

1.61

0.62

1.4

1.0

—

Unstable angina pectoris

0.00

0.61

0.0

1.1

—

Presence of cardiac and vascular implants and grafts

0.00

0.61

0.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.58

0.61

1.0

1.1

—

Acute appendicitis, no complications

1.66

0.61

1.0

1.1

—

Other anxiety disorders

0.00

0.60

0.0

1.2

—

Other symptoms and signs involving cognitive functions and awareness

0.00

0.60

0.0

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

1.53

0.59

1.0

1.1

—

Heart failure and coronary heart disease

0.00

0.59

0.0

1.1

—

Headache

1.78

0.59

1.0

1.2

—

Implicit Sepsis

1.77

0.59

1.0

1.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.75

0.59

1.2

—

1.75

0.59

1.2

—

Gonarthrosis [arthrosis of knee](FG)

1.73

0.58

1.0

1.1

—

Dizziness and giddiness

1.73

0.58

1.3

1.1

—

Other intervertebral disc disorders

1.70

0.57

1.2

1.1

—

Implicit Sepsis, including avohilmo

1.65

0.56

1.0

1.2

—

Acute appendicitis

1.64

0.56

1.0

1.1

—

Dermatitis and eczema

1.52

0.55

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.60

0.54

1.0

1.2

—

Appendicitis, broad definition

1.58

0.54

1.0

1.1

—

Diseases of appendix

1.58

0.54

1.0

1.1

—

Cystitis

1.60

0.50

1.3

1.0

—

Metabolic disorders

1.45

0.46

1.0

1.1

—

Diabetes, varying definitions

1.45

0.43

1.0

1.1

—

Diabetes mellitus

1.44

0.43

1.0

1.1

—

Gonarthrosis

1.57

0.42

1.0

1.1

—

Infections of the skin and subcutaneous tissue

1.59

0.42

1.0

1.1

—

Pain in throat and chest

1.56

0.42

1.0

1.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.41

0.0

1.1

—

N06DA Anticholinesterases

0.00

0.41

0.0

1.1

—

Use of anticholinesterases

0.00

0.41

0.0

1.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.00

0.41

0.0

1.2

—

Lyme disease, including avohilmo

0.00

0.41

0.0

1.1

—

Lyme disease

0.00

0.41

0.0

1.1

—

Spirochaetal infections, other/unspecified, including avohilmo

0.00

0.41

0.0

1.1

—

Rheumatoid arthritis, including avohilmo

0.00

0.41

0.0

1.1

—

Primary coxarthrosis, bilateral

0.00

0.41

0.0

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

0.00

0.41

0.0

1.1

—

Type 2 diabetes, wide definition

1.50

0.41

1.0

1.1

—

Rheumatoid arthritis

0.00

0.41

0.0

1.1

—

Peripheral artery disease

0.00

0.41

0.0

1.1

—

Shoulder lesions

1.50

0.41

1.0

1.1

—

Contraceptive management

0.00

0.41

0.0

1.0

—

Hypertensive diseases

1.48

0.40

1.0

1.1

—

Hypertension

1.48

0.40

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

1.45

0.40

1.0

1.1

—

Dermatophytosis, including avohilmo

1.44

0.39

1.4

1.1

—

Myocardial infarction, without ST-elevation

0.00

0.39

0.0

1.1

—

Hypothyroidism, strict autoimmune

1.43

0.39

1.2

1.0

—

Diseases of external ear

0.00

0.39

0.0

1.1

—

Other heart diseases, wide

1.40

0.35

1.0

1.2

—

Gonarthrosis,primary

1.39

0.35

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

1.37

0.35

1.2

1.1

—

Selective serotonin reuptake inhibitors

1.36

0.34

1.2

1.1

—

Dorsopathies

1.36

0.32

1.1

—

Other joint disorders

1.35

0.32

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases

1.26

0.30

1.3

1.0

—

Other disorders of urethra and urinary system

1.34

0.23

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.24

0.22

1.2

1.1

—

Artificial joint operation, meniscal resection

1.23

0.22

1.0

1.1

—

Female infertility

0.00

0.22

0.0

1.0

—

Single delivery by caesarean section

0.00

0.22

0.0

1.0

—

Injuries to the shoulder and upper arm

1.20

0.22

1.2

1.1

—

Hypertensive Heart Disease

0.00

0.21

0.0

1.1

—

Long labour

0.00

0.21

0.0

1.0

—

Hypertensive heart and/or renal disease

0.00

0.21

0.0

1.1

—

Special screening examination for infectious and parasitic diseases

0.00

0.21

0.0

1.1

—

Haemorrhage from respiratory passages

0.00

0.21

0.0

1.1

—

Diabetic retinopathy, strict definition

0.00

0.21

0.0

1.0

—

Impacted teeth

0.00

0.21

0.0

1.3

—

Type 1 diabetes

0.00

0.21

0.0

1.2

—

Tinnitus

0.00

0.21

0.0

1.2

—

Fibroblastic disorders

0.00

0.21

0.0

1.2

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.21

0.0

1.1

—

Speech therapy

0.00

0.21

0.0

1.2

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.21

0.0

1.1

—

Seropositive rheumatoid arthritis, wide

0.00

0.21

0.0

1.1

—

Chronic gastritis

0.00

0.21

0.0

1.2

—

Erosion of teeth , including avohilmo

0.00

0.21

0.0

1.3

—

Psoriasis

0.00

0.21

0.0

1.2

—

Deviated nasal septum

0.00

0.21

0.0

1.1

—

Other hearing loss

0.00

0.21

0.0

1.2

—

Symptoms and signs involving the digestive system and abdomen

1.31

0.21

1.0

1.2

—

Polyuria

0.00

0.21

0.0

1.2

—

Preterm labour and delivery

0.00

0.21

0.0

1.0

—

All dysplastic lesions of the cervix uteri

0.00

0.21

0.0

1.3

—

Sub-endpoint used in defining T1D endpoints

0.00

0.21

0.0

1.2

—

Coronary artery bypass grafting

0.00

0.21

0.0

1.1

—

Postpartum haemorrhage

0.00

0.21

0.0

1.0

—

False labour

0.00

0.21

0.0

1.0

—

Convulsions, not elsewhere classified

0.00

0.20

0.0

1.3

—

Other disorders of ear

1.25

0.20

1.0

1.1

—

Status post-ami

0.00

0.20

0.0

1.1

—

Postpartum hemorraghe, parous women as controls

0.00

0.20

0.0

1.3

—

Other (not insulin) diabetes medications

1.21

0.20

1.0

1.1

—

Postpartum hemorraghe, all women as controls

0.00

0.20

0.0

1.2

—

Mycoses, including avohilmo

1.17

0.19

1.3

1.1

—

Autoimmune diseases

1.18

0.18

1.4

1.0

—

Sleep disorders (combined)

1.18

0.18

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

1.17

0.18

1.0

1.1

—

Injuries to the knee and lower leg

1.17

0.17

1.1

—

Other specific joint derangements/joint disorders

1.15

0.10

1.0

1.1

—

General symptoms and signs

1.16

0.09

1.0

1.2

—

Chronic periodontitis, including avohilmo

1.13

0.09

1.0

1.1

—

Periodontitis

1.12

0.09

1.0

1.1

—

Nerve, nerve root and plexus disorders

1.06

0.08

1.0

1.1

—

Injuries to the head

1.09

0.08

1.0

1.1

—

Diseases of the ear and mastoid process

1.06

0.08

1.3

1.1

—

Melanocytic naevi of trunk

0.00

0.0

1.2

—

Superficial injury of abdomen, lower back and pelvis

0.00

0.0

1.2

—

Antenatal screening

0.00

0.0

1.0

—

Seropositive rheumatoid arthritis

0.00

0.0

1.3

—

Use of donepezil

0.00

0.0

1.0

—

Endometriosis ASRM stages 3,4

0.00

0.0

1.3

—

Hypertrophy of breast

0.00

0.0

1.1

—

Supervision of high-risk pregnancy

0.00

0.0

1.0

—

Puerperal sepsis

0.00

0.0

1.2

—

Retinal breaks without detachment

0.00

0.0

1.2

—

Diabetic maculopathy

0.00

0.0

1.0

—

Superficial injury of ankle and foot

0.00

0.0

1.2

—

Dysplasia of cervi uteri

0.00

0.0

1.0

—

Chronic apical periodontitis

0.91

0.00

1.0

1.1

—

Otitis media, unspecified

0.00

0.0

1.1

—

Maternal care for known or suspected malpresentation of fetus

0.00

-0.00

0.0

1.0

—

Parkinson's disease, strict definition, excluding more controls

0.00

-0.00

0.0

1.2

—

Injury of muscle and tendon at lower leg level

0.00

-0.00

0.0

1.2

—

Continuous positive airway pressure

0.00

-0.00

0.0

1.4

—

Other respiratory diseases principally affecting the interstitium

0.00

-0.00

0.0

1.2

—

Abnormal findings on diagnostic imaging of other body structures

0.00

-0.00

0.0

1.2

—

Examination and encounter for administrative purposes

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in transport accident

0.00

-0.00

0.0

1.1

—

Car occupant injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.2

—

Other condition

0.00

-0.00

0.0

1.2

—

Traumatic subdural haemorrhage

0.00

-0.00

0.0

1.1

—

Type 1 diabetes, wide definition, subgroup 1

0.00

-0.00

0.0

1.3

—

Injury of muscle and tendon at wrist and hand level

0.00

-0.00

0.0

1.2

—

Injury of eye and orbit

0.00

-0.00

0.0

1.2

—

Superficial injury of hip and thigh

0.00

-0.00

0.0

1.2

—

HSIL lesion of the cervix uteri

0.00

-0.00

0.0

1.4

—

Gingivitis and periodontal diseases

0.96

-0.00

1.0

1.1

—

Other dorsopathies, not elsewhere classified

1.00

-0.00

1.0

1.1

—

L02BA Anti-estrogens

0.00

-0.00

0.0

1.2

—

Faecal incontinence

0.00

-0.00

0.0

1.2

—

Soft tissue disorders

0.95

-0.00

1.0

1.1

—

Multiple delivery

0.00

-0.00

0.0

1.0

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

-0.00

0.0

1.0

—

Inflammatory diseases of prostate (prostatitis)

0.00

-0.00

0.0

1.1

—

Trochanteric bursitis

0.00

-0.00

0.0

1.2

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.6

—

Arthropathic psoriasis

0.00

-0.00

0.0

1.2

—

Hyperkinetic disorders

0.00

-0.00

0.0

1.5

—

Valvular operations

0.00

-0.00

0.0

1.2

—

Childhood allergy (age < 16)

0.00

-0.00

0.0

1.3

—

malignant neoplasm of female genital organs, including Hilmo

0.00

-0.00

0.0

1.2

—

Myocardial infarction, unclassifiable

0.00

-0.00

0.0

1.1

—

Migraine with aura and triptan purchases

0.00

-0.00

0.0

1.3

—

Seborrhoeic keratosis

0.00

-0.00

0.0

1.3

—

Other (seronegative) rheumatoid arthritis, wide

0.00

-0.00

0.0

1.2

—

Fracture of femur

0.00

-0.00

0.0

1.0

—

Type 1 diabetes, wide definition

0.00

-0.00

0.0

1.3

—

Disturbance of activity and attention

0.00

-0.00

0.0

1.5

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

1.0

—

Certain disorders involving the immune mechanism

0.00

-0.00

0.0

1.2

—

Other keratitis

0.00

-0.00

0.0

1.2

—

Wet age-related macular degeneration

0.00

-0.00

0.0

1.0

—

Acne

0.00

-0.00

0.0

1.6

—

Cervicobrachial syndrome

0.00

-0.00

0.0

1.2

—

Ganglion

0.00

-0.00

0.0

1.2

—

Hallux rigidus

0.00

-0.00

0.0

1.3

—

Other hammer toe(s) (acquired)

0.00

-0.00

0.0

1.1

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.2

—

Stomatitis and related lesions

0.00

-0.00

0.0

1.1

—

Hyperkinetic disorders, excluding more controls

0.00

-0.00

0.0

1.2

—

Spondylolisthesis/Spondylolysis

0.00

-0.00

0.0

1.2

—

Benign mammary dysplasia

0.00

-0.00

0.0

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.01

-0.00

1.4

1.0

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.4

—

Hydrocele

0.00

-0.00

0.0

1.1

—

Unspecified lump in breast

0.00

-0.00

0.0

1.2

—

Thoracic aortic aneurysm

0.00

-0.00

0.0

1.2

—

Coeliac disease

0.00

-0.00

0.0

1.2

—

Benign neoplasm of ovary

0.00

-0.00

0.0

1.2

—

Psoriasis vulgaris

0.00

-0.00

0.0

1.3

—

Polyarthrosis

0.00

-0.00

0.0

1.2

—

Enthesopathies of lower limb, excluding foot

0.00

-0.00

0.0

1.2

—

Seropositive rheumatoid arthritis, strict definition

0.00

-0.00

0.0

1.2

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

0.00

-0.00

0.0

1.2

—

Biguanides

1.01

-0.00

1.0

1.1

—

Other female pelvic inflammatory diseases

0.00

-0.00

0.0

1.2

—

Infections of genitourinary tract in pregnancy

0.00

-0.00

0.0

1.6

—

Obstructed labour due to maternal pelvic abnormality

0.00

-0.00

0.0

1.0

—

Maternal care for known or suspected fetal abnormality and damage

0.00

-0.00

0.0

1.0

—

Ectopic pregnancy

0.00

-0.00

0.0

1.1

—

Prolonged pregnancy

0.00

-0.00

0.0

1.0

—

Use of rivastigmine

0.00

-0.00

0.0

1.0

—

Disorder of lipoprotein metabolism, unspecified

0.00

-0.00

0.0

1.2

—

Sarcoidosis

0.00

-0.00

0.0

1.2

—

Fracture of foot, except ankle

0.00

-0.00

0.0

1.3

—

Palmar fascial fibromatosis [Dupuytren]

0.00

-0.00

0.0

1.2

—

Presbycusis

0.00

-0.00

0.0

1.0

—

Otitis externa

0.00

-0.00

0.0

1.3

—

Recurrent aphthous stomatitis , including avohilmo

0.00

-0.00

0.0

1.2

—

Misadventures to patients during surgical and medical care

0.00

-0.00

0.0

1.2

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Urine sediment comments by Light microscopy Narrative

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS